BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Jiangsu Topcel-KH Pharmaceutical readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Jiangsu Topcel-KH Pharmaceutical'
 s drugs run\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06925594-86@assetmemo.bio
DTSTAMP:20261121T005002Z
DTSTART;VALUE=DATE:20261228
DTEND;VALUE=DATE:20261229
SUMMARY:TH-SC01: Phase 3 readout est. (NCT06925594)
DESCRIPTION:TH-SC01\, phase 3\, Crohn's Disease.\nStudy: Phase 3 Study of H
 uman TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients Wit
 h Crohn's Disease\nEstimated primary completion: 28 December 2026. This is
  a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can
  move.\nDrug page: https://assetmemo.bio/drug/th-sc01#upcoming-events\nReg
 istry record: https://clinicaltrials.gov/study/NCT06925594
URL:https://assetmemo.bio/drug/th-sc01#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
